The Zeposia Market is projected to witness robust growth over the coming years, driven by a surge in autoimmune disease prevalence, a growing geriatric population, and increasing awareness of oral S1P receptor modulators. According to Dataintelo, the global market value stood at USD 1.52 billion in 2023 and is expected to reach USD 3.94 billion by 2032, expanding at a CAGR of 11.2% from 2024 to...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek